Perspectives on Enquiry & Evidence

There is recognized heterogeneity within any given tumor‐type from patient to patient (inter‐patient heterogeneity),..

Popular statistical designs, such as CRM (O’Quigley et al., 1990), mTPI-2 (Guo et al., 2017), and i3+3 (Liu et al.,..

Synthetic control arms (SCAs) leverage real world data from various sources or evaluations of historical clinical data..

With only two weeks left for this fabulous year to end, we would like to thank all our blog subscribers and new readers..

  Cytel is delighted to have Kannan Natarajan speaking at the “Complex Innovative Trial Design Symposium and East User..